PERNIX THERAPEUTICS HOLDINGS, INC. - FORM 10-Q - EX-32.1 - 906 CERTIFICATE - November 9, 2018

Attached files

file filename
EX-3.1 - ARTICLES SUPPLEMENTARY FOR 0% SERIES C PERPETUAL CONVERTIBLE PREFERRED STOCK - PERNIX THERAPEUTICS HOLDINGS, INC.exh3-1.htm
EX-31.2 - CFO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-2.htm
EX-31.1 - CEO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-1.htm
EX-10.8 - FIRST SUPPLEMENTAL INDENTURE, DATED JULY 27, 2018, BETWEEN PERNIX THERAPEUTICS H - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-8.htm
EX-10.7 - AMENDMENT NO. 2 TO THE TERM FACILITY, DATED AUGUST 1, 2018, BY AND AMONG PIP DAC - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-7.htm
EX-10.6 - AMENDMENT NO. 3 TO THE ABL FACILITY, AUGUST 1, 2018, BY AND AMONG PERNIX, THE GU - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-6.htm
EX-10.2 - SERVICES AGREEMENT, DATED JULY 27, 2018, BETWEEN NALPROPION PHARMACEUTICALS, INC - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-2.htm
EX-10.1 - STOCKHOLDERS AGREEMENT, DATED JULY 27, 2018, BY AND AMONG NALPROPION PHARMACEUTI - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-1.htm
10-Q - 10-Q - PERNIX THERAPEUTICS HOLDINGS, INC.body10q.htm

EXHIBIT 32.1

CERTIFICATION UNDER SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this periodic report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of Pernix Therapeutics Holdings, Inc. for the periods covered by this periodic report.

Date: November 9, 2018

 

/s/ JOHN SEDOR

 

 

 

John Sedor

 

 

 

Chairman and Chief Executive Officer
(Principal Executive Officer)

 

 

 

 

 

Date: November 9, 2018

 

/s/ ANGUS SMITH

 

 

 

Angus Smith
Senior Vice President and Chief Business Officer and Principal Financial Officer

 

 

 

(Principal Financial Officer)

 

 

PERNIX THERAPEUTICS HOLDINGS, INC. Reports